<DOC>
	<DOCNO>NCT01923987</DOCNO>
	<brief_summary>Radical treatment primary rectal cancer synchronous distant metastasis include surgical resection primary metastatic lesion . However , primary rectal cancer case metastasize disease often locally advanced disease need downsize surgery . It report pelvic recurrence rate distant metastasis rate outside liver 30~35 % 60 % , respectively . Therefore , combine treatment radiotherapy chemotherapy use . However , sequence treatment modality yet definitely establish preoperative chemoradiotherapy surgical resection accept option treatment . Conventional long course chemoradiotherapy delay administration full-dose chemotherapy , metastatic lesion progress chemoradiotherapy . In present study , evaluate efficacy short course radiotherapy ( SCRT ) follow full-dose chemotherapy delay surgical resection primary tumor metastasis .</brief_summary>
	<brief_title>Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery Rectal Cancer With Synchronous Distant Metastasis</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma rectum Lower margin tumor within 12 cm anal verge Clinically locally advance ( T34 N12 ) disease Potentially resectable synchronous distant metastasis liver and/or lung . The resectability metastatic lesion determine size , number , location , general condition , liver function , lung function . Over 18 year Eastern Cooperative Oncology Group performance status 02 Proper organ function ( Hemoglobin ≥ 10 g/dl , Absolute neutrophil count ( ANC ) ≥ 1,500/mm3 , Platelet ≥ 100,000/mm3 , Creatinine ≤ 1.5 mg/dl , Clearance creatinine &gt; 50 ml/min use CockcroftGault formula , Bilirubin ≤ 1.5 x upper limit normal ( ULN ) , Liver enzyme ( Aspartate aminotransferase/Alanine transaminase/Alkaline phosphatase ) ≤ 2.5 x ULN ) Subject sign inform consent form participate trial . Metastases organ except liver lung History type malignancy within 3 year nonmelanoma skin carcinoma situ cervix Hereditary colorectal cancer ( FAP , HNPCC , etc ) Bowel obstruction impend bowel obstruction Uncontrolled severe illness , unsuitable chemoradiotherapy ( within 6 month , myocardial infarct , unstable angina , heart failure , uncontrolled arrhythmia , uncontrolled epilepsy , central nervous system disease , psychological disorder , etc ) Subject pregnant breast feeding , incapable appropriate contraception Unresected synchronous colorectal cancer History prior pelvic radiotherapy History prior chemotherapy colorectal cancer Great surgery within 4 week study enrollment Participant trial within 4 week study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Short course radiotherapy</keyword>
	<keyword>Modified FOLFOX6</keyword>
	<keyword>Delayed surgery</keyword>
	<keyword>Rectal cancer</keyword>
	<keyword>Synchronous metastasis</keyword>
	<keyword>Liver metastasis</keyword>
	<keyword>Lung metastasis</keyword>
</DOC>